Myeloma Paper of the Day, September 15th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, September 15th, suggested by Robert Orlowski / A. Huart, A. Lazareth, A. Perrot, B. De Renzis, B. Lioure, C. Louni, dialysis, F.
Related Articles
Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor
The inhibition of mutant KRAS proteins has emerged as a promising approach for treating KRAS-driven cancers, as evidenced by the clinical success of KRAS G12C…
TikTok · Dr. Elisabeth Potter
555.2K likes, 15.8K comments. “It’s 2025, and navigating insurance has somehow gotten even more out of control… I just performed two bilateral DIEP flap surgeries…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Treatment of Pleural Mesothelioma: ASCO Guideline Update
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
Oncology-focused Postdoctoral Training In Care Delivery and Symptom
Funded by a National Cancer Institute research training grant (1T32CA275764-01A1), the Oncology-focused Postdoctoral Training In Care Delivery and Symptom Science (OPTICS) Training Program at Memorial…
Welcome! You are invited to join a webinar: IACH Webinar- GVHD: Highlights from #ASH24. After registering, you will receive a confirmation email about joining the webinar.
Speaker: Florent Malard Florent Malard is Professor of Hematology at the Saint-Antoine Hospital and Sorbonne University. Florent Malard was a visiting investigator at the Memorial…
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
PURPOSENeoadjuvant immune checkpoint blockade with nivolumab plus ipilimumab improves overall survival (OS) in non–small cell lung cancer (NSCLC); however, randomized data for resectable lung cancer…
The Year Britain Finally Buried Thatcher’s Privatization Legacy
The UK’s souring experience of privatized public services may presage a definitive breach with an epoch-defining policy.
Investors call on UnitedHealth to disclose human and economic costs of policies that limit care
Health insurers like UnitedHealth are under tremendous public scrutiny for tactics such as prior authorization and care denials.